Industry News, Content and Resources
Implications for Medical Affairs Teams in 2024 and Beyond
In 2024, medical affairs teams are pivotal in driving strategic impact within the pharmaceutical industry. They navigate challenges in organizational transformation, artificial intelligence (AI) integration, and omnichannel engagement. Transforming organizational structures involves alignment with broader goals and excelling in scientific engagement. AI offers potential to streamline [...]
Aerial Contagion: Redefining Airborne Pathogens
The World Health Organization (WHO) has recently announced a revision of its classification of airborne pathogens, including SARS-CoV-2, after criticism of delayed recognition during the pandemic. The WHO's technical report replaces the previous three categories of viral transmission airborne, droplet, and aerosol, with "infectious respiratory particles". [...]
ImmunityBio’s Combination Therapy Approved for Bladder Cancer
The U.S. Food and Drug Administration (FDA) has recently approved ImmunityBio's combination therapy for vaccine-resistant bladder cancer. As this condition affects 75-85% of bladder cancer patients, finding suitable therapies is urgent. This approval is a exciting turnaround for the company, which previously faced FDA rejection due [...]
Bridging Urban-Rural Healthcare Gaps Through Real-World Data
Medical research and clinical trials have historically favored urban communities, resulting in an underrepresentation of rural communities. Real-world data (RWD) gathered from sources like electronic health records offers insights that transcend geographic limitations, revealing how factors like limited access to healthcare impact the health outcomes of [...]
Chiesi Focuses on Patient-Centered Care in Fabry Disease
Chiesi Global Rare Diseases has published survey results in the Orphanet Journal of Rare Diseases that underscore the persistent awareness gap and unique struggles of rare disease patients, specifically those with Fabry disease. Giacomo Chiesi emphasizes the importance of understanding the disease from a patient's viewpoint [...]
ISPOR 2024: Keynote Speakers and Sessions Announced
The ISPOR 2024 conference, a key event for Health Economics and Outcomes Research (HEOR), will take place from May 5th to 8th in Atlanta, Georgia. This global gathering, of which is expected to draw nearly 5000 participants, will explore the theme "HEOR: A Transformative Force for [...]
Forecast of the Global Real World Evidence (RWE) Solutions Market
The Global Real World Evidence (RWE) Solutions Market is forecasted to grow from 2.7 billion (USD) in 2023 to 5.8 billion by 2033, with a CAGR of 7.9% from 2024 to 2033, as per Market.us. This growth is driven by the increasing utility of RWE in strategic [...]
Bristol Myers Squibb Expands Partnership with Cellares in $380 Million Deal
Bristol Myers Squibb (BMS) has reinforced its collaboration with Cellares by signing a $380 million agreement, securing exclusive access to automated CAR-T cell therapy manufacturing units across the U.S., Europe, and Japan. Building on an initial $255 million investment in Cellares’ Series C funding, this deal [...]
Entyvio: New Subcutaneous Option for Crohn’s Disease Patients
Takeda's Entyvio, a medication for Crohn's disease, has been approved for a subcutaneous (SC) formulation. Originally an intravenous (IV) infusion drug from 2014, this new option allows patients to self-administer the treatment with a prefilled pen, offering convenience and flexibility for at-home use. Takeda announced this [...]
Urgent Transparency Needed in H5N1 Bird Flu Outbreaks Affecting U.S. Dairy Cattle
As H5N1 bird flu spreads across U.S. dairy cattle herds, significant concerns have arisen regarding the virus's impact on cattle and the potential risks to human health. Initially detected in a Texas dairy herd, the virus has since been identified in 29 herds across eight states. [...]
Addressing Challenges in Pharmaceutical Innovation through Strategic Collaboration and Digital Transformation
The pharmaceutical industry faces critical challenges, including focusing on profit-driven blockbuster drugs at the expense of niche treatments and rare diseases. This has led to medication shortages and compromised patient care, underscoring the need for innovative solutions, especially in areas like cancer treatment and bacterial-resistant infections. [...]
Abbott’s Q1 2024 Earnings: Strong Medical Device Sales Lead to Raised Financial Forecasts
Abbott Laboratories experienced a robust first quarter in 2024, driven primarily by its medical devices segment. This resulted in overall sales surpassing Wall Street forecasts and an updated, optimistic financial outlook for the year. The company reported a 2.2% increase in total sales year-over-year, reaching $10 [...]
Expansion and Enhancement of Telehealth and Teletherapy Services Post-Pandemic
The pandemic significantly highlighted the benefits of telehealth, making remote medical consultations a preferred choice for many, especially those with recurring conditions who consult regularly with their physicians. This shift in preference has persisted even after the pandemic, leading to the expansion of teletherapy services. A [...]
Biden Administration Launches Global Health Security Strategy to Combat Infectious Diseases
The Biden administration has unveiled a comprehensive plan to strengthen global health security by assisting 50 countries, predominantly in Africa and Asia, to enhance their infectious disease response capabilities. Announced amidst ongoing difficulties in solidifying a global pandemic treaty, this initiative seeks to improve testing, surveillance, [...]
Study Reveals Racial Disparities in Prostate Cancer Care
A landmark study conducted by Analysis Group has highlighted significant racial disparities in the treatment and survival of patients with metastatic castration-sensitive prostate cancer (mCSPC). Published in Prostate Cancer and Prostatic Diseases, the research revealed that Black patients were considerably less likely to receive novel hormonal [...]